Search Result

Pathways Recommended:	JAK/STAT Signaling MAPK/ERK Pathway

Results for "

IL-6/JAK/STAT3 pathway

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Interleukin Related (7) JAK (13) STAT (16) Akt (2) AMPK (1) Apoptosis (9) Atg8/LC3 (3) Autophagy (5) Bcl-2 Family (2) c-Myc (2) Caspase (3) CDK (1) Discoidin Domain Receptor (1) Endogenous Metabolite (1) Ferroptosis (3) Glucocorticoid Receptor (1) GSK-3 (1) HSP (1) Influenza Virus (1) MEK (1) NF-κB (2) Oxidative Phosphorylation (1) p38 MAPK (1) p62 (3) PARP (1) PERK (1) PROTACs (1) Raf (1) Ras (1) Reactive Oxygen Species (ROS) (3) Reference Standards (1) TNF Receptor (3)
By Research Areas:	Cancer (13) Cardiovascular Disease (5) Infection (1) Inflammation/Immunology (8) Metabolic Disease (1) Neurological Disease (1)

By Targets:

Interleukin Related (7)

JAK (13)

STAT (16)

Akt (2)

AMPK (1)

Apoptosis (9)

Atg8/LC3 (3)

Autophagy (5)

Bcl-2 Family (2)

c-Myc (2)

Caspase (3)

CDK (1)

Discoidin Domain Receptor (1)

Endogenous Metabolite (1)

Ferroptosis (3)

Glucocorticoid Receptor (1)

GSK-3 (1)

HSP (1)

Influenza Virus (1)

MEK (1)

NF-κB (2)

Oxidative Phosphorylation (1)

p38 MAPK (1)

p62 (3)

PARP (1)

PERK (1)

PROTACs (1)

Raf (1)

Ras (1)

Reactive Oxygen Species (ROS) (3)

Reference Standards (1)

TNF Receptor (3)

By Research Areas:

Cancer (13)

Cardiovascular Disease (5)

Infection (1)

Inflammation/Immunology (8)

Metabolic Disease (1)

Neurological Disease (1)

Inhibitors & Agonists

Natural
Products

Targets Recommended: STAT Tissue Factor Pathway Inhibitor (TFPI) JAK Interleukin Related IRAK Itk

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N1356

Reticuline 1 Publications Verification	JAK STAT NF-κB Endogenous Metabolite	Cardiovascular Disease Inflammation/Immunology
Reticuline shows anti-inflammatory effects through *JAK2/STAT3* and NF-κB signaling pathways. Reticuline inhibits mRNA expressions of TNF-α, and IL-6 and reduces the phosphorylation levels of JAK2 and STAT3 . Reticuline exhibits cardiovascular effects .

HY-N6069

Raspberry ketone glucoside 1 Publications Verification	Interleukin Related JAK STAT	Inflammation/Immunology
Raspberry ketone glucoside is a melanogenesis inhibitor. Raspberry ketone glucoside inhibits melanogenesis by activating the *IL6/JAK1/STAT3* pathway, inhibiting the transcriptional activity of MITFa, and its downstream expression levels of the TYR and TYRP1a genes. Raspberry ketone glucoside shows remarkable whitening activity on both B16F10 cells in vitro and zebrafish model in vivo .

HY-168894

CT-1	Ferroptosis JAK STAT p38 MAPK AMPK GSK-3 Apoptosis HSP TNF Receptor	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
CT-1 is a secreted protein belonging to the *IL-6* cytokine family. Overexpression of CT-1 enhances cell proliferation, migration and angiogenesis via the ADMA/DDAH pathway. CT-1 inhibits the growth of triple-negative breast cancer cells by simultaneously inducing Ferroptosis in N2-type tumor-associated neutrophils and cancer cells. CT-1 activates the *Jak/STAT-3*, p42/p44 MAPK and AMPK pathways, and inhibits GSK-3β activity through phosphorylation to induce cardiomyocyte hypertrophy. CT-1 enhances the viability of cardiomyocytes and neurons, reduces cell Apoptosis, induces the expression of heat shock proteins (HSP) and BNP, and inhibits TNF levels. CT-1 exerts anti-tumor activity in mouse models of triple-negative breast cancer. CT-1 improves cognitive impairment in mice. CT-1 is applicable to the research of ischemic heart disease, triple-negative breast cancer, myocardial hypertrophy, Parkinson's disease, hypertensive heart disease, myocardial infarction, acute Chagas cardiomyopathy, high-fat diet-induced cognitive impairment and diabetes-related cognitive impairment .

HY-150538

STAT3-IN-12 1 Publications Verification	STAT Apoptosis	Cancer
STAT3-IN-12 is a potent *STAT3* signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in cancer-related research, such as hepatocellular carcinoma (HCC) and oesophageal carcinoma .

HY-153190

W1131 1 Publications Verification	Oxidative Phosphorylation STAT Ferroptosis	Cancer
W1131 is a potent *STAT3* inhibitor, triggering ferroptosis. W1131 suppresses cancer progression in gastric cancer cell subcutaneous xenograft model, organoids model, and PDX model. W1131 effectively alleviates chemical resistance of cancer cells to 5-FU (HY-90006). W1131 regulates cell cycle, DNA damage response, and oxidative phosphorylation, including *IL6-JAK-STAT3* pathway and ferroptosis pathway .

HY-13559

Atiprimod Azaspirane ; SKF 106615-12; SKF 106615A12	STAT Apoptosis Autophagy Reactive Oxygen Species (ROS) Caspase Bcl-2 Family p62 Atg8/LC3 PARP NF-κB PERK JAK	Cardiovascular Disease Inflammation/Immunology Cancer
Atiprimod (Azaspirane) is a *STAT3* inhibitor with antitumor, anti-inflammatory, and anti-angiogenic activities. Atiprimod blocks the signaling pathways of IL-6 and VEGF by inhibiting the phosphorylation of signal transducer and activator of *STAT3. Atiprimod blocks the JAK-STAT* signaling pathway by inhibiting the phosphorylation of *JAK2* and *JAK3. Atiprimod also inhibits cell proliferation, induces cell cycle arrest, and induces autophagy* and apoptosis. Atiprimod triggers persistent ER stress-mediated apoptosis in breast cancer cells by activating the PERK/eIF2α/ATF4/CHOP axis and inhibiting the nuclear translocation of *STAT3/NF-κB*. Atiprimod shows great anti-tumor activities in tumor xenograft mouse models. Atiprimod can be used for the study of pituitary adenoma, breast cancer, multiple myeloma and acute myeloid leukemia (AML) .

HY-N6069R

Raspberry ketone glucoside (Standard)	Reference Standards Interleukin Related JAK STAT	Inflammation/Immunology
Raspberry ketone glucoside (Standard) is the analytical standard of Raspberry ketone glucoside (HY-N6069). Raspberry ketone glucoside is a melanogenesis inhibitor. Raspberry ketone glucoside inhibits melanogenesis by activating the *IL6/JAK1/STAT3* pathway, inhibiting the transcriptional activity of MITFa, and its downstream expression levels of the TYR and TYRP1a genes. Raspberry ketone glucoside shows remarkable whitening activity on both B16F10 cells in vitro and zebrafish model in vivo .

HY-175771

STAT3-IN-46	STAT c-Myc Bcl-2 Family Interleukin Related JAK	Cancer
STAT3-IN-46 is a selective and orally active inhibitor of signal transducer and activator of transcription 3 (STAT3) (K_D = 323.3 nM). STAT3-IN-46 directly binds to the SH2 domain of the STAT3 and inhibits IL-6/JAK/STAT3 signaling pathway (IC₅₀ = 0.87 μM) and downregulates c-Myc and Bcl-2 levels. STAT3-IN-46 can be used for the research of cancer, such as triple-negative breast cancer .

HY-13559A

Atiprimod dimaleate Azaspirane dimaleate; SKF 106615-12 dimaleate; SKF 106615A12 dimaleate	STAT Apoptosis Caspase Interleukin Related Autophagy Reactive Oxygen Species (ROS) Atg8/LC3 p62 JAK	Cardiovascular Disease Inflammation/Immunology Cancer
Atiprimod (Azaspirane) (dimaleate) is a *STAT3* inhibitor with antitumor, anti-inflammatory, and anti-angiogenic activities. Atiprimod blocks the signaling pathways of IL-6 and VEGF by inhibiting the phosphorylation of signal transducer and activator of *STAT3. Atiprimod blocks the JAK-STAT* signaling pathway by inhibiting the phosphorylation of *JAK2* and *JAK3. Atiprimod also inhibits cell proliferation, induces cell cycle arrest, and induces autophagy* and apoptosis. Atiprimod triggers persistent ER stress-mediated apoptosis in breast cancer cells by activating the PERK/eIF2α/ATF4/CHOP axis and inhibiting the nuclear translocation of *STAT3/NF-κB*. Atiprimod shows great anti-tumor activities in tumor xenograft mouse models. Atiprimod can be used for the study of pituitary adenoma, breast cancer, multiple myeloma and acute myeloid leukemia (AML) .

HY-110102

Atiprimod hydrochloride Azaspirane hydrochloride; SKF 106615-12 hydrochloride; SKF 106615	JAK STAT Apoptosis Autophagy Reactive Oxygen Species (ROS) Caspase Atg8/LC3 p62	Cardiovascular Disease Inflammation/Immunology Cancer
Atiprimod (Azaspirane) hydrochloride is a *STAT3* inhibitor with antitumor, anti-inflammatory, and anti-angiogenic activities. Atiprimod blocks the signaling pathways of IL-6 and VEGF by inhibiting the phosphorylation of signal transducer and activator of *STAT3. Atiprimod blocks the JAK-STAT* signaling pathway by inhibiting the phosphorylation of *JAK2* and *JAK3. Atiprimod also inhibits cell proliferation, induces cell cycle arrest, and induces autophagy* and apoptosis. Atiprimod triggers persistent ER stress-mediated apoptosis in breast cancer cells by activating the PERK/eIF2α/ATF4/CHOP axis and inhibiting the nuclear translocation of *STAT3/NF-κB*. Atiprimod shows great anti-tumor activities in tumor xenograft mouse models. Atiprimod can be used for the study of pituitary adenoma, breast cancer, multiple myeloma and acute myeloid leukemia (AML) .

HY-176876

Glucocorticoid receptor/IL-6-IN-1	Glucocorticoid Receptor Interleukin Related JAK STAT	Inflammation/Immunology
Glucocorticoid receptor/IL-6-IN-1 (Compound 35) is a selective dual inhibitor targeting the glucocorticoid receptor (GR) and *IL-6* signaling pathway (IC₅₀ values of 120 nM and 59 nM, respectively). Glucocorticoid receptor/IL-6-IN-1 inhibits IL-6-induced JAK/STAT3 phosphorylation, blocking inflammatory cytokine transcription. Glucocorticoid receptor/IL-6-IN-1 is promising for research of inflammatory diseases like rheumatoid arthritis and asthma .

HY-153858

PHI-501	Raf Discoidin Domain Receptor MEK TNF Receptor Interleukin Related JAK STAT Ras	Cancer
PHI-501 is a dual inhibitor targeting RAF/DDR. PHI-501 exhibits significant anti-proliferative effects in melanoma cell lines and significantly inhibits the colony formation of drug-resistant cells. PHI-501 strongly inhibits ERK and AKT phosphorylation. PHI-501 downregulates the gene sets in drug-resistant cells of TNFA-NFKB, *IL6-JAK-STAT3, and KRAS* signaling pathways as well as the epithelial-mesenchymal transition (EMT) signaling pathways. PHI-501 demonstrates significant anti-tumor effects in the SK-MEL3DR xenograft model. PHI-501 can be used for research on the problem of drug resistance in melanoma .

HY-103438A

BIBU1361 dihydrochloride	Apoptosis Autophagy Akt	Cancer
BIBU1361 dihydrochloride induces apoptosis and inhibits autophagy. BIBU1361 inhibits pro-survival pathways Akt/mTOR and *gp130/JAK/STAT3, and decreased levels of pro-inflammatory cytokine IL-6* .

HY-103438

BIBU1361	Apoptosis Akt Autophagy	Cancer
BIBU1361 induces apoptosis and inhibits autophagy. BIBU1361 inhibits pro-survival pathways Akt/mTOR and *gp130/JAK/STAT3, and decreased levels of pro-inflammatory cytokine IL-6* .

HY-153190A

W1131 TFA 1 Publications Verification	Ferroptosis STAT	Cancer
W1131 TFA is a potent STAT3 inhibitor that induces ferroptosis. W1131 inhibits cancer progression in subcutaneous xenograft, organoid, and PDX models of gastric cancer. W1131 effectively alleviates cancer cell chemoresistance to 5-FU (HY-90006). W1131 regulates the cell cycle, DNA damage response, and oxidative phosphorylation, including the IL6-JAK-STAT3 pathway and the ferroptosis pathway .

HY-181514

STAT3-IN-53	STAT CDK c-Myc Apoptosis	Cancer
STAT3-IN-53 (Compound L20) is a *STAT3* inhibitor with a K_d value of 6.16 μM. STAT3-IN-53 binds directly to the SH2 domain of *STAT3, inhibits phosphorylation at the Y705 site without affecting the total STAT3* protein level, and suppresses the IL-6/JAK/STAT3 pathway. STAT3-IN-53 downregulates the transcription and expression of cyclin-D1 and c-Myc. STAT3-IN-53 induces cell cycle arrest and promotes Apoptosis. STAT3-IN-53 exhibits anticancer activity against colorectal cancer .

HY-181691

JAK2-IN-20	JAK Influenza Virus	Infection
JAK2-IN-20 is an orally active dual inhibitor targeting *JAK2* kinase (IC₅₀=49.17 nM) and influenza A virus PB2 protein (IC₅₀=3.337 μM, K_d=2.82 μM). JAK2-IN-20 effectively blocks the *JAK/STAT* signaling pathway by reducing the phosphorylation levels of *STAT1* and *STAT3, thereby inhibiting viral replication and downregulating the expression of viral NP and PB2* proteins. In addition, JAK2-IN-20 significantly inhibits the mRNA expression of key inflammatory cytokines such as IL-6, TNF-α and IFN-β in inflammation and influenza infection models. JAK2-IN-20 serves as an important tool molecule for the study of influenza A virus infection and related pathologies .

HY-115438

AUH-6-96	JAK STAT Apoptosis	Cancer
AUH-6-96 is a *JAK/STAT* signaling inhibitor. AUH-6-96 reduces Unpaired-induced transcriptional activity in Drosophila cells and blocks tyrosine phosphorylation of STAT92E. AUH-6-96 blocks both constitutive and IL-6-induced phosphorylation of *STAT3. AUH-6-96 decreases the level of tyrosine-phosphorylated JAK3. AUH-6-96 induces cancer cell Apoptosis by downregulating the expression of anti-apoptotic genes downstream of STAT3. AUH-6-96 selectively reduces the viability of cancer cells with abnormal JAK/STAT signaling pathway*. AUH-6-96 is applicable to related research on Hodgkin's lymphoma, breast cancer, and prostate cancer .

HY-179715

PROTAC JAK1/2 degrader-1	PROTACs JAK TNF Receptor Interleukin Related STAT	Inflammation/Immunology
PROTAC JAK1/2 degrader-1 (Compound A8) is a selective JAK1/2 PROTAC degrader, with DC₅₀ values of 1.4 μM for JAK1 and 0.92 μM for JAK2. PROTAC JAK1/2 degrader-1 significantly inhibits the release of NO, *IL-6* (IC₅₀ = 12.89 μM) and TNF-α (IC₅₀ = 17.17 μM). PROTAC JAK1/2 degrader-1 significantly alleviates inflammatory responses and colonic damage by inhibiting the *JAK/STAT3* signaling pathway. PROTAC JAK1/2 degrader-1 can be used for research on colitis. (Pink: JAK1/2 ligand (HY-179716); Blue: CRBN ligand (HY-10984); Black: linker; CRBN ligand + linker (HY-131888A)) .

Reticuline 1 Publications Verification	Cardiovascular Disease Alkaloids Classification of Application Fields Phenols Polyphenols Plants Lauraceae Isoquinoline Alkaloids Lindera aggregata (Sims) Kosterm. Disease Research Fields Source Classification	JAK STAT NF-κB Endogenous Metabolite
Reticuline shows anti-inflammatory effects through *JAK2/STAT3* and NF-κB signaling pathways. Reticuline inhibits mRNA expressions of TNF-α, and IL-6 and reduces the phosphorylation levels of JAK2 and STAT3 . Reticuline exhibits cardiovascular effects .

Raspberry ketone glucoside 1 Publications Verification	Classification of Application Fields Ketones, Aldehydes, Acids Rosaceae Plants Rubus corchorifolius Linn. f. Inflammation/Immunology Disease Research Fields Source Classification	Interleukin Related JAK STAT
Raspberry ketone glucoside is a melanogenesis inhibitor. Raspberry ketone glucoside inhibits melanogenesis by activating the *IL6/JAK1/STAT3* pathway, inhibiting the transcriptional activity of MITFa, and its downstream expression levels of the TYR and TYRP1a genes. Raspberry ketone glucoside shows remarkable whitening activity on both B16F10 cells in vitro and zebrafish model in vivo .

Raspberry ketone glucoside (Standard)	Structural Classification Ketones, Aldehydes, Acids Rosaceae Plants Rubus corchorifolius Linn. f. Source Classification	Reference Standards Interleukin Related JAK STAT
Raspberry ketone glucoside (Standard) is the analytical standard of Raspberry ketone glucoside (HY-N6069). Raspberry ketone glucoside is a melanogenesis inhibitor. Raspberry ketone glucoside inhibits melanogenesis by activating the *IL6/JAK1/STAT3* pathway, inhibiting the transcriptional activity of MITFa, and its downstream expression levels of the TYR and TYRP1a genes. Raspberry ketone glucoside shows remarkable whitening activity on both B16F10 cells in vitro and zebrafish model in vivo .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.

IL-6/JAK/STAT3 pathway

Inhibitors & Agonists

NaturalProducts

Natural
Products